Table 2.
Prevalence of prescription and over-the-counter medication usage
| Medication | Category | Total sample (n = 97) | (OPC Synergy® + Catalyn®) (n = 31) | (Ginkgo Synergy® + Choline) (n = 33) | Placebo (n = 33) | Statistic | |
|---|---|---|---|---|---|---|---|
| Current prescription |
Anti-depressant |
Yes |
11 (11.3%) |
6 (19.4%) |
1 (3%) |
4 (12.1%) |
X2(2) = 4.3, p = 0.12 |
| No |
86 (88.7%) |
25 (80.6%) |
32 (97%) |
29 (87.9%) |
|||
| Beta blocker |
Yes |
7 (7.2%) |
4 (12.9%) |
3 (9.1%) |
- |
X2(2) = 4.2, p = 0.12 |
|
| No |
90 (92.8%) |
27 (87.1%) |
30 (90.1%) |
33 (100%) |
|||
| Anti-hypertensive |
Yes |
25 (25.8%) |
9 (29%) |
9 (27.3%) |
7 (21.2%) |
X2(2) = 0.6, p = 0.75 |
|
| No |
72 (74.2%) |
22 (71%) |
24 (72.2%) |
26 (78.8%) |
|||
| Anti-hypercholesterol |
Yes |
11 (11.3%) |
7 (22.6%) |
1 (3%) |
3 (9.1%) |
X2(2) = 6.3, p = 0.04 |
|
| No |
86 (88.7%) |
19 (77.4%) |
32 (97%) |
30 (90.1%) |
|||
| Laxative |
Yes |
7 (7.2%) |
2 (6.5%) |
3 (9.1%) |
2 (6.1%) |
X2(2) = 0.3, p = 0.88 |
|
| No |
90 (92.8%) |
29 (93.5%) |
30 (90.1%) |
31 (93.9%) |
|||
| Insomnia |
Yes |
10 (10.3%) |
3 (9.7%) |
4 (12.1%) |
3 (9.1%) |
X2(2) = 0.2, p = 0.91 |
|
| No |
87 (89.7%) |
28 (90.3%) |
29 (87.9%) |
30 (90.1%) |
|||
| OTC in the prior week | Aspirin |
Yes |
33 (34%) |
10 (32.3%) |
14 (42.4%) |
9 (27.3%) |
X2(2) = 1.8, p = 0.42 |
| No |
64 (66%) |
21 (67.7%) |
19 (57.6%) |
24 (72.2%) |
|||
| Tylenol |
Yes |
34 (35.1%) |
12 (38.7%) |
13 (39.4%) |
9 (27.3%) |
X2(2) = 1.3, p = 0.51 |
|
| No |
63 (64.9%) |
19 (61.3%) |
20 (60.6%) |
24 (72.2%) |
|||
| Antacid |
Yes |
13 (13.4%) |
6 (19.4%) |
5 (15.2%) |
2 (6.1%) |
X2(2) = 2.6, p = 0.28 |
|
| No |
84 (86.6%) |
25 (80.6%) |
28 (84.8%) |
31 (93.9%) |
|||
| Vitamin/mineral | Yes |
67 (69.1%) |
21 (67.7%) |
25 (75.8%) |
21 (63.6%) |
X2(2) = 1.2, p = 0.56 | |
| No | 30 (30.9%) | 10 (32.3%) | 8 (24.2%) | 12 (36.4%) | |||